-
1
-
-
84885917963
-
High burden of iron deficiency and different types of anemia in inflammatory bowel disease outpatients in Scandinavia: a longitudinal 2-year follow-up study
-
Bager P., Befrits R., Wikman O., et al. High burden of iron deficiency and different types of anemia in inflammatory bowel disease outpatients in Scandinavia: a longitudinal 2-year follow-up study. Scand J Gastroenterol 2013, 48:1286-1293.
-
(2013)
Scand J Gastroenterol
, vol.48
, pp. 1286-1293
-
-
Bager, P.1
Befrits, R.2
Wikman, O.3
-
2
-
-
84889651633
-
Anaemia in inflammatory bowel disease: a population-based 10-year follow-up
-
Høivik M.L., Reinisch W., Cvancarova M., et al. Anaemia in inflammatory bowel disease: a population-based 10-year follow-up. Aliment Pharmacol Ther 2014, 39:69-76. IBSEN Study Group.
-
(2014)
Aliment Pharmacol Ther
, vol.39
, pp. 69-76
-
-
Høivik, M.L.1
Reinisch, W.2
Cvancarova, M.3
-
3
-
-
84880039507
-
Hepcidin is a key mediator of anemia of inflammation in Crohn's disease
-
Basseri R.J., Nemeth E., Vassilaki M.E., et al. Hepcidin is a key mediator of anemia of inflammation in Crohn's disease. J Crohns Colitis 2013, 7:e286-e291.
-
(2013)
J Crohns Colitis
, vol.7
, pp. e286-e291
-
-
Basseri, R.J.1
Nemeth, E.2
Vassilaki, M.E.3
-
4
-
-
84891903512
-
Interleukin-6 directly impairs the erythroid development of human TF-1 erythroleukemic cells
-
McCranor B.J., Kim M.J., Cruz N.M., et al. Interleukin-6 directly impairs the erythroid development of human TF-1 erythroleukemic cells. Blood Cells Mol Dis 2014, 52:126-133.
-
(2014)
Blood Cells Mol Dis
, vol.52
, pp. 126-133
-
-
McCranor, B.J.1
Kim, M.J.2
Cruz, N.M.3
-
5
-
-
84925840755
-
Iron deficiency: the hidden miscreant in inflammatory bowel disease
-
Allocca M., Fiorino G., Danese S. Iron deficiency: the hidden miscreant in inflammatory bowel disease. Curr Drug Targets 2014, 15:1011-1019.
-
(2014)
Curr Drug Targets
, vol.15
, pp. 1011-1019
-
-
Allocca, M.1
Fiorino, G.2
Danese, S.3
-
6
-
-
84890452446
-
Commentary: anaemia in inflammatory bowel disease-the most common and ignored extra intestinal manifestation
-
Fiorino G., Allocca M., Danese S. Commentary: anaemia in inflammatory bowel disease-the most common and ignored extra intestinal manifestation. Aliment Pharmacol Ther 2014, 39:227-228.
-
(2014)
Aliment Pharmacol Ther
, vol.39
, pp. 227-228
-
-
Fiorino, G.1
Allocca, M.2
Danese, S.3
-
7
-
-
84927693448
-
Anaemia from a patient perspective in inflammatory bowel disease: results from the European Federation of Crohn's and Ulcerative Colitis Association's online survey
-
Danese S., Hoffman C., Vel S., et al. Anaemia from a patient perspective in inflammatory bowel disease: results from the European Federation of Crohn's and Ulcerative Colitis Association's online survey. Eur J Gastroenterol Hepatol 2014, 26:1385-1391.
-
(2014)
Eur J Gastroenterol Hepatol
, vol.26
, pp. 1385-1391
-
-
Danese, S.1
Hoffman, C.2
Vel, S.3
-
8
-
-
84941742838
-
Persistent or recurrent anemia is associated with severe and disabling inflammatory bowel disease
-
Koutroubakis I.E., Ramos-Rivers C., Regueiro M., et al. Persistent or recurrent anemia is associated with severe and disabling inflammatory bowel disease. Clin Gastroenterol Hepatol 2015, 13:1760-1766.
-
(2015)
Clin Gastroenterol Hepatol
, vol.13
, pp. 1760-1766
-
-
Koutroubakis, I.E.1
Ramos-Rivers, C.2
Regueiro, M.3
-
9
-
-
84928603336
-
European consensus on the diagnosis and management of iron deficiency and anaemia in inflammatory bowel diseases
-
Dignass A.U., Gasche C., Bettenworth D., et al. European consensus on the diagnosis and management of iron deficiency and anaemia in inflammatory bowel diseases. J Crohns Colitis 2015, 9:211-222.
-
(2015)
J Crohns Colitis
, vol.9
, pp. 211-222
-
-
Dignass, A.U.1
Gasche, C.2
Bettenworth, D.3
-
10
-
-
84941648961
-
Iron replacement in patients with inflammatory bowel disease: a systematic review and meta-analysis
-
Abhyankar A., Moss A.C. Iron replacement in patients with inflammatory bowel disease: a systematic review and meta-analysis. Inflamm Bowel Dis 2015, 21:1976-1981.
-
(2015)
Inflamm Bowel Dis
, vol.21
, pp. 1976-1981
-
-
Abhyankar, A.1
Moss, A.C.2
-
11
-
-
84891619733
-
Treatment of anemia in inflammatory bowel disease-systematic review and meta-analysis
-
Avni T., Bieber A., Steinmetz T., et al. Treatment of anemia in inflammatory bowel disease-systematic review and meta-analysis. PLoS One 2013, 8:e75540.
-
(2013)
PLoS One
, vol.8
, pp. e75540
-
-
Avni, T.1
Bieber, A.2
Steinmetz, T.3
-
12
-
-
84858075234
-
Iron replacement therapy in inflammatory bowel disease patients with iron deficiency anemia: a systematic review and meta-analysis
-
Lee T.W., Kolber M.R., Fedorak R.N., et al. Iron replacement therapy in inflammatory bowel disease patients with iron deficiency anemia: a systematic review and meta-analysis. J Crohns Colitis 2012, 6:267-275.
-
(2012)
J Crohns Colitis
, vol.6
, pp. 267-275
-
-
Lee, T.W.1
Kolber, M.R.2
Fedorak, R.N.3
-
13
-
-
84874568807
-
Ferric carboxymaltose prevents recurrence of anemia in patients with inflammatory bowel disease
-
Evstatiev R., Alexeeva O., Bokemeyer B., et al. Ferric carboxymaltose prevents recurrence of anemia in patients with inflammatory bowel disease. Clin Gastroenterol Hepatol 2013, 11:269-277.
-
(2013)
Clin Gastroenterol Hepatol
, vol.11
, pp. 269-277
-
-
Evstatiev, R.1
Alexeeva, O.2
Bokemeyer, B.3
-
14
-
-
84908240451
-
Current practice in the diagnosis and management of IBD-associated anaemia and iron deficiency in Germany: the German AnaemIBD Study
-
Blumenstein I., Dignass A., Vollmer S., et al. Current practice in the diagnosis and management of IBD-associated anaemia and iron deficiency in Germany: the German AnaemIBD Study. J Crohns Colitis 2014, 8:1308-1314.
-
(2014)
J Crohns Colitis
, vol.8
, pp. 1308-1314
-
-
Blumenstein, I.1
Dignass, A.2
Vollmer, S.3
-
15
-
-
84884551031
-
Iron deficiency generates secondary thrombocytosis and platelet activation in IBD: the randomized, controlled thromboVIT trial
-
Kulnigg-Dabsch S., Schmid W., Howaldt S., et al. Iron deficiency generates secondary thrombocytosis and platelet activation in IBD: the randomized, controlled thromboVIT trial. Inflamm Bowel Dis 2013, 19:1609-1616.
-
(2013)
Inflamm Bowel Dis
, vol.19
, pp. 1609-1616
-
-
Kulnigg-Dabsch, S.1
Schmid, W.2
Howaldt, S.3
-
16
-
-
84932085425
-
The influence of anti-tumor necrosis factor agents on hemoglobin levels of patients with inflammatory bowel disease
-
Koutroubakis I.E., Ramos-Rivers C., Regueiro M., et al. The influence of anti-tumor necrosis factor agents on hemoglobin levels of patients with inflammatory bowel disease. Inflamm Bowel Dis 2015, 21:1587-1593.
-
(2015)
Inflamm Bowel Dis
, vol.21
, pp. 1587-1593
-
-
Koutroubakis, I.E.1
Ramos-Rivers, C.2
Regueiro, M.3
-
17
-
-
84940791825
-
Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity 2011
-
Accessed June 8
-
World Health Organization. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity 2011. Available from: . Accessed June 8, 2015. http://www.who.int/vmnis/indicators/haemoglobin/en/.
-
(2015)
-
-
|